COAGADEX

This brand name is authorized in Austria, Estonia, Croatia, Ireland, Lithuania, Poland, United Kingdom

Active ingredients

The drug COAGADEX contains one active pharmaceutical ingredient (API):

1 Coagulation factor X UNII 0P94UQE6SY - COAGULATION FACTOR X HUMAN

Coagulation factor X is derived from human plasma and used as a replacement for the naturally existing coagulation factor X in patients with hereditary factor X deficiency. Read about Coagulation factor X

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
COAGADEX Powder and solvent for solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BD13		B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1713776, 1713787
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 327525, 360753
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1079856, 1079857
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100367737, 100367743